Cynata Therapeutics Ltd has released a press release.
Update on Discussions with Sumitomo and Fujifilm
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- Response to ASX Aware Query
- Response to ASX Price and Volume Query
- Cynata confirms receipt of indicative non-binding proposal
- June 2019 Quarterly Report
- Cynata Strengthens Board & Executive Management Team
Later from Cynata Therapeutics
- Fujifilm Exercises License Option in GvHD
- Cynata Receives US$3 million Fujifilm License Fee
- CYP Advances Towards Osteoarthritis Phase 2 Clinical Trial
- Cynata & Sumitomo Withdraw from Acquisition Discussions
- September 2019 Quarterly Report
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics